December 18, 2007 - Gaithersburg, Maryland - Panacea Pharmaceuticals' lung cancer diagnostic test, LC Detectsm, has been named one of Time Magazine's Ten Biggest Medical Breakthroughs of 2007. LC Detectsm is a simple blood test to facilitate the identification of lung cancer, even among individuals with early-stage disease... LC Detectsm measures levels of human aspartyl (asparaginyl) beta;-hydroxylase (HAAH), a cancer molecular marker, in blood. HAAH has been detected by immunohistochemical staining in a broad range of cancers, including lung cancer, and has been shown to be highly specific and absent in adjacent non-affected tissue as well as tissue from cancer-free individuals... Panacea's Press Release -
Blog Archive
-
▼
2007
(90)
-
▼
December
(6)
- Panacea Pharmaceuticals' Lung Cancer Diagnostic Te...
- Infinity and Medimmune, Phase 2 Trial of IPI-504 t...
- Theravance, GSK1160724, Phase 1 Clinical Study Wit...
- Discovery Labs, Aerosurf Improves Lung Function a...
- Rigel , Initiation of Phase 1 Clinical Trial of R...
- IDM Pharma, IDM-2101 Updated Phase 2 Results Show ...
-
▼
December
(6)